September 15, 2015 Press Release Mitsubishi Tanabe Pharma Corporation MT-4666 in Alzheimer’s Disease Discontinuation of Global Phase 3 Clinical Trial Program in Japan - Alzheimer's disease - Document - PDFSEARCH.IO

First Page	Meta Content
	September 15, 2015 Press Release Mitsubishi Tanabe Pharma Corporation MT-4666 in Alzheimer’s Disease Discontinuation of Global Phase 3 Clinical Trial Program in Japan Add to Reading List Document Date: 2015-09-14 18:35:46 Open Document File Size: 112,37 KB Share Result on Facebook

September 15, 2015 Press Release Mitsubishi Tanabe Pharma Corporation MT-4666 in Alzheimer’s Disease Discontinuation of Global Phase 3 Clinical Trial Program in JapanAdd to Reading List